| |
NewswireTODAY - /newswire/ -
Pangbourne, Berkshire, United Kingdom, 2010/04/21 - Themis Analytics, a leading provider of business intelligence and marketing information services and solutions for the global pharmaceutical industry, is announced today as a winner of the coveted Queen’s Award for Enterprise in International Trade.
|
| |
The Queen’s Awards for Enterprise are the UK’s most prestigious awards for business performance. They recognise and reward outstanding achievement by UK companies. For Wiltshire based company, Themis Analytics, this award has been given most notably for the increase in exports that have tripled over the last six years, and also in recognition of its significant and consistent growth. This outstanding achievement is testament to a highly effective marketing strategy which has grown out of the ability to establish and maintain long term, in-depth relationships with the head offices and regional offices of global clients. Themis Analytics’ client base includes some of the world’s leading corporations, many of whom have been partnering with Themis Analytics for many years. In fact, 80% of the company’s turnover last year was due to repeat business.
Themis Analytics was founded 17 years ago by David Holmes, from his home in a Wiltshire farmhouse. David explains, ‘After a career in Pharmaceutical Marketing Research, I realised there was a real need to make better use of the data we were creating as an industry. ‘Themis’ was a Greek goddess tasked with organising the affairs of men and my original idea was just this: that it should be a lot easier to organise and integrate data into information with a graphical view of trends to aid in decision making. We began our journey with just one major pharmaceutical client, and now, 17 years later, they still form part of our ever increasing client base of blue-chip companies. The original vision has been realised and our teams in the UK and the USA are supporting customers around the world. We are proud and delighted to have been recognised by the Queens Award’.
Themis Analytics has a keen focus on monitoring trends within the industry and developing its solutions to fulfil client needs. CEO Greg Schlimm comments, ‘The pharmaceutical industry today faces more challenges than ever before, and the complexity is increasing as drug launches become more niche and specialised. Over the years we have consistently pushed ourselves to utilise leading edge technologies to create more sophisticated market offerings. In order to support this monumental change in the industry, we are launching Themis Version 7 this summer with a whole set of new analytic capabilities for more individualised needs. Our market offerings are now even broader and we have seen our customer base grow significantly, however, our core value proposition to our clients remains firmly based on David’s original vision. This award recognises our dedication and commitment and has inspired us to continue to aim for excellence.’
About Themis Analytics
Themis Analytics (themisanalytics.com) is a leading provider of business intelligence solutions specifically designed to meet the business needs of the pharmaceutical industry. Founded in 1993, the company has 17 years of experience in providing leading edge market intelligence products and services to thousands of users across 70 countries, representing many of the world’s leading corporations. Themis Analytics’ mission and goal is to enable any decision maker, anywhere in the world, at any time, to access the best data source available. Thus enabling them to understand the dynamics of the market and to make decisions with confidence.
|
liz[.]onefishtwofish.co.uk 
